Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile



1 DNA Way

South San Francisco  California  94080-4990  U.S.A.
Phone: 650-225-1000 Fax: 650-225-6000

Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego. Today, the campus spans 60 acres and includes a multi-product, biotech manufacturing and clinical operations complex with six buildings totaling 500,000 square feet. Upon receiving U.S. Food and Drug Administration licensure in 2007, the Oceanside facility added 90,000 liters of capacity that are now approved for the production of Rituxan and Avastin bulk drug substance.

On the Southern California Coast, halfway between Los Angeles and San Diego, Oceanside is a beautiful beachfront community of roughly 200,000 people. As one of Oceanside’s largest employers, Genentech takes great pride in the impact we have on the community, but also in the impact the community has on our employees.

Please view our company video on YouTube:

Connect with us via Social Media:




 Key Statistics

Ownership: Subsidiary

Web Site: Genentech
Employees: 10,000+
Symbol: RHHBY



 Company News
Constellation Pharmaceuticals Quietly Cuts 23 Employees as Genentech (RHHBY)'s Decision Looms 1/19/2015 6:25:09 AM
Genentech (RHHBY) Strikes DNA Sequencing Deal With Genome Pioneer Venter 1/14/2015 9:31:29 AM
Genentech (RHHBY) Reveals Their Greatest Source of Who They Hire 1/7/2015 12:53:41 PM
23andMe, Genentech (RHHBY) Forge $60 Million Parkinson's Research Deal 1/6/2015 11:06:53 AM
Genentech (RHHBY) Release: FDA Approves Gazyva® (Obinutuzumab) Supplemental Biologics License Application With New Data In Previously Untreated Chronic Lymphocytic Leukemia 12/29/2014 9:52:14 AM
Phylogica Ltd. Grabs $142 Million Deal With Genentech (RHHBY) 12/22/2014 8:44:19 AM
Genentech (RHHBY) Provides Update On Phase 3 MARIANNE Study In People With Previously Untreated Advanced HER2-Positive Breast Cancer 12/19/2014 6:09:33 AM
FDA Breakthrough Status For Genentech (RHHBY)'s Lucentis 12/16/2014 6:33:51 AM
Gilead Sciences, Inc. (GILD) Poaches Genentech (RHHBY) Exec To Head Cancer Drug Program 12/15/2014 8:41:32 AM
Genentech (RHHBY) Submits New Drug Application To FDA For Investigational Cobimetinib Used In Combination With Zelboraf (Vemurafenib) In Advanced Melanoma 12/15/2014 6:02:57 AM